Santander Aktie

4,79 EUR -0,09 EUR -1,81 %

16:23:14

XETRA

4,77 EUR -0,13 EUR -2,58 %

16:54:08

BTE

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.72,71 Mrd. EUR

KGV5,77Div. Rendite3,77%

WKN858872

ISINES0113900J37

SymbolBCDRF

Santander Aktien News

Sortieren:Datum Meistgelesen

02.03.24Financial TimesSantander shareholders urged to vote against Botín pay package

02.03.24PR NewswireSAN INVESTOR NEWS: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Banco Santander, S.A. Investors to Inquire About Securities Class Action Investigation - SAN

24.02.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Banco Santander, S.A. - SAN

19.02.24Financial TimesSantander returns record profits to investors in bid to boost shares

16.02.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Banco Santander, S.A. - SAN

09.02.24ZacksIs Banco Santander (SAN) Stock Undervalued Right Now?

09.02.24BBCNationwide's Dominic West advert reported by Santander to watchdog

05.02.24BenzingaBanco Santander, Lloyds Banking And Other Big Stocks Moving Lower In Monday's Pre-Market Session

05.02.24MarketWatchSantander, Lloyds shares fall on report Iran used banks to evade sanctions

05.02.24BenzingaIran Allegedly Used Lloyds And Santander To Circumvent US Sanctions: Report

05.02.24Financial TimesFirstFT: Iran used Lloyds and Santander accounts to evade sanctions

04.02.24Financial TimesIran used Lloyds and Santander accounts to evade sanctions

01.02.24BenzingaEarnings Preview: Banco Santander Chile

31.01.24Financial TimesSantander earnings boosted by strong performance in Europe

30.01.24ZacksBanco Santander (SAN) Upgraded to Strong Buy: Here's What You Should Know

30.01.24BenzingaBanco Santander Earnings Preview

24.01.24BBCSantander ups mortgage rates despite fierce competition

14.11.23PR NewswireBirchway Tropicana Aims to Bring High Quality Living at Value Pricing to Las Vegas

01.11.23PR NewswireSanofi launches "The 1 Pledge" movement to drive early screening for type 1 diabetes in the U.S.

13.09.23PR NewswireSanofi and rapper/actor Ice-T unveil trailer for The Season as a warning against the flu

25.07.23PR NewswireSanofi Consumer Healthcare North America Earns B Corp Certification in Recognition of Environmental, Social Impact

04.04.23PR NewswireSanofi Breaks Ground on State-of-the-Art Facility in Swiftwater for Sustainable Production of Pandemic Flu Vaccines

27.01.23PR NewswireBetty Jotanovic Is Named President of Chrysler Capital and Auto Relationships at Santander Consumer

18.01.23PR NewswireSanofi launches first global scholarship program for students from underrepresented communities pursuing careers in healthcare

21.12.22PR NewswirePositive Dupixent® (dupilumab) Phase 3 Results in Adults and Adolescents with Eosinophilic Esophagitis Published in the New England Journal of Medicine

16.12.22PR NewswireDupixent® (dupilumab) Recommended for EU Approval by the CHMP for the Treatment of Eosinophilic Esophagitis

15.12.22PR NewswireDupixent® (dupilumab) Approved by European Commission as the First and Only Targeted Medicine Indicated for Prurigo Nodularis

11.11.22PR NewswireDupixent® (dupilumab) Recommended for EU Approval by the CHMP for the Treatment of Prurigo Nodularis

11.10.22PR NewswireDupixent® (dupilumab) Late-Breaking Phase 3 Data Presented at UEG Week 2022 Showed Significant Histological Remission of Eosinophilic Esophagitis (EoE) in Children 1 to 11 Years Old

06.10.22PR NewswireSanofi US enters into co-promotion agreement with Provention Bio, Inc. to launch teplizumab, an investigational disease-modifying therapy for type 1 diabetes

28.09.22PR NewswireDupixent® (dupilumab) Approved by FDA as the First and Only Treatment Indicated for Prurigo Nodularis

05.09.22PR NewswireLate-Breaking Dupixent® (dupilumab) Data at ERS 2022 Show Consistent Efficacy and Safety Profile for Up to Two Years in Children Aged 6 to 11 Years with Moderate-to-severe Asthma

12.08.22PR NewswirePublic health experts underscore importance of flu vaccinations to help reduce health inequities among high-risk populations

05.08.22PR NewswireSantander Bank Teams Up with Rocket Mortgage to Provide Clients with Digitally Driven Home Loan Experience

03.08.22PR NewswireSanofi appoints new Heads of U.S. General Medicines, and North America Vaccines and Consumer Healthcare

26.07.22PR NewswireSanofi partners with Howard University in an unprecedented pharmacy fellowship program

01.07.22PR NewswireSanofi flu vaccines licensed and approved for 2022-2023 influenza season, including CDC preferred higher-dose vaccines for adults 65+

07.06.22PR NewswireFDA Approves Dupixent® (dupilumab) as First Biologic Medicine for Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis

Santander News

Santander News: auf dieser Seite finden Sie alle Santander News und Nachrichten zur Santander Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Santander News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Santander News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.